doxycycline NDC 68999-417

NDC codes

FDA NDC Directory

Product NDC (as listed)68999-417Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68999-0417Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68999-417-46	68999041746	60 mL in 1 BOTTLE, GLASS (68999-417-46)Marketed from Sep 1, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): doxycycline
Generic name (nonproprietary): doxycycline
Active ingredients: Doxycycline — 25 mg/5mL
Dosage form: Powder, For suspension
Route: Oral
Labeler: Chartwell Governmental & Specialty RX, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 065454
Marketing start: Jul 16, 2008
Listing expires: Dec 31, 2026
Other FDA classes: Tetracyclines (Chemical structure)
Identifiers: Product ID 68999-417_40076faf-09c3-f4ab-e063-6394a90ab3c1SPL ID 40076faf-09c3-f4ab-e063-6394a90ab3c1SPL set ID b8486639-7eb9-4610-9cd4-0e922045d592RxCUI 1649405, 1649988, 1650030, 1650143, 1652674UNII N12000U13O, 19XTS3T51UUPC 0368999626404, 0368999626282, 0368999625605, 0368999985501, 0368999984504, 0368999417460, 0368999626305, 0368999626060, 0368999626312, 0368999626503
Pharmacologic class: Tetracycline-class Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468999041746 followed by a unit qualifier and the quantity

Package 68999-0417-46. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 30, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE To reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline and other antibacterial drugs, doxycycline should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Treatment Doxycycline is indicated for the treatment of the following infections Rocky Mountain spotted fever, typhus fever and the typhus group, Q fev…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 065454

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 065454
Product	Strength	Form · route	Labeler	Product NDC
doxycycline	Doxycycline 25 mg/5mL	Powder, For suspensionOral	Chartwell RX LLC	62135-877
doxycycline	Doxycycline 25 mg/5mL	Powder, For suspensionOral	Chartwell RX LLC	62135-417